The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection; report of 10 cases and meta-analysis

作者: N. Yageashi , T. Niinuma , H. Chisaka , T. Watanabe , S. Uehara

DOI: 10.1016/S0163-4453(98)90346-2

关键词:

摘要: Objectives to clarify the approximation of frequency B19-related nonimmune hydrops fetalis (NIHF), and know critical period during which maternal infection led NIHF. Methods we investigated characteristics 10 cases antenatal B19 diagnosed over past years in Miyagi prefecture, Japan, performed a meta-analysis these those previously reported literature. Results NIHF caused by intrauterine was between 11 23 weeks gestaton women Japan. The source mother's older child six out cases, children at kindergarten where mothers worked two cases. interval onset diagnosis ranged from 2 6 weeks. responsible for (15.2%) 66 actiology unknown this study, 57 (19.1%) 299 non-malformed or aetilogy-unknown Meta-analysis 165 infection, including described above, showed that there 10.2%, excess risk fetal death infected with pregnancy 12.4% first 20 pregnancy. Transplacental transmission confirmed 69 (24.1%) 286 mean gestational age 22.8 ± 5.1 6.2 3.7 Conclusions approximations will be useful counselling management pregnant women. correlated hepatic hematopoietic activity. These findings suggest parvovirus may have an affinity erythroid lineage cells stage hematopoiesis, strongly influence clinical features feto-maternal infection.

参考文章(94)
N Yaegashi, H Shiraishi, T Takeshita, M Nakamura, A Yajima, K Sugamura, Propagation of human parvovirus B19 in primary culture of erythroid lineage cells derived from fetal liver Journal of Virology. ,vol. 63, pp. 2422- 2426 ,(1989) , 10.1128/JVI.63.6.2422-2426.1989
Anders Selbing, Ann Josefsson, LarsOlav Dahle, Richard Lindgren, PARVOVIRUS B19 INFECTION DURING PREGNANCY TREATED WITH HIGH-DOSE INTRAVENOUS GAMMAGLOBULIN The Lancet. ,vol. 345, pp. 660- 661 ,(1995) , 10.1016/S0140-6736(95)90569-3
P D Knott, G A Welply, M J Anderson, Serologically proved intrauterine infection with parvovirus. BMJ. ,vol. 289, pp. 1660- 1660 ,(1984) , 10.1136/BMJ.289.6459.1660
Pascal Cassinotti, Manfred Weitz, Günter Siegl, Human parvovirus B19 infections: routine diagnosis by a new nested polymerase chain reaction assay. Journal of Medical Virology. ,vol. 40, pp. 228- 234 ,(1993) , 10.1002/JMV.1890400311
M. Zerbini, M. Musiani, G. Gentilomi, S. Venturoli, G. Gallinella, D. Gibellini, R. Morandi, B. Guerra, L. Bovicelli, M. La Placa, Symptomatic Parvovirus B19 Infection of One Fetus in a Twin Pregnancy Clinical Infectious Diseases. ,vol. 17, pp. 262- 263 ,(1993) , 10.1093/CLINIDS/17.2.262
Sheila M. Gillespie, Occupational Risk of Human Parvovirus B19 Infection for School and Day-care Personnel During an Outbreak of Erythema Infectiosum JAMA: The Journal of the American Medical Association. ,vol. 263, pp. 2061- 2065 ,(1990) , 10.1001/JAMA.1990.03440150069028
Heather A. Cubie, John Grzybowski, Chandu Da Silva, linda Duncan, Tom Brown, Nicholas M. Smith, Synthetic oligonucleotide cocktails as probes for detection of human parvovirus B19 Journal of Virological Methods. ,vol. 53, pp. 91- 102 ,(1995) , 10.1016/0166-0934(94)00179-K
Andreas Nerlich, TinoF Schwarz, Michael Roggendorf, Hedwig Roggendorf, Eva Ostermeyer, Thomas Schramm, Karl-Philip Gloning, Parvovirus B19-infected erythroblasts in fetal cord blood The Lancet. ,vol. 337, pp. 310- ,(1991) , 10.1016/0140-6736(91)90932-F
Asad U. Sheikh, Joseph M. Ernest, Michael O’Shea, Long-term outcome in fetal hydrops from parvovirus B19 infection American Journal of Obstetrics and Gynecology. ,vol. 167, pp. 337- 341 ,(1992) , 10.1016/S0002-9378(11)91411-2
TinoF. Schwarz, M. Roggendorf, Barbara Hottenträger, Friedrich Deinhardt, Gisela Enders, KarlP. Gloning, Thomas Schramm, Manfred Hansmann, Human parvovirus B19 infection in pregnancy. The Lancet. ,vol. 332, pp. 566- 567 ,(1988) , 10.1016/S0140-6736(88)92684-0